Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
KFSHRC Successfully Conducts Pharmacogenetic Analysis for Over 1,500 Patients
RIYADH, Saudi Arabia, Oct.21, 2024(GLOBE NEWSWIRE) -- Since its launch in early September last year, King Faisal Specialist Hospital & Research Centre (KFSHRC) has successfully conducted pharmacogenetic analysis for over 1,500 patients, as a novel medical approach, focusing on tailoring medications to patient's DNA (genetic code), allowing for precise predictions of drug efficacy and the selection of the most effective and safest treatments. This represents a significant shift from...
Nasdaq GlobeNewswire
21/10/2024
BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on…
MAINZ, Germany, October 21, 2024 (GLOBE NEWSWIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2024 on Monday, November 4, 2024. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. ET (2:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update. To access the live conference call via telephone, please...
Nasdaq GlobeNewswire
21/10/2024
Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating…
Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW171 in treatment of ovarian cancer, non-small cell lung cancer (NSCLC), and other mesothelin (MSLN) expressing cancers VANCOUVER, British Columbia, Oct.21, 2024(GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that the...
Nasdaq GlobeNewswire
21/10/2024
Portuguese Transplant Center Analysis of First 100 Cases of Hypothermic…
"In our analysis, HOPE increased the use of marginal grafts and provided good function of the grafts in the immediate postoperative period," said Maria João Amaral, General Surgery Department - Unidade Local de Saúde de Coimbra, Portugal and principal investigator of the analysis. "In addition, there was a decrease in the non-anastomotic strictures (NAS) rate in our Center," she added. "In our analysis, HOPE increased the use of marginal grafts and provided good function…
PR Newswire
21/10/2024
Leonard A. Lauder is honored with the Neiman Marcus Award for Distinguished…
"Leonard Lauder is a singular force who forever changed the beauty industry. His stewardship led The Estée Lauder Companies to become home to some of the world's most beloved beauty brands," said Geoffroy van Raemdonck, Chief Executive Officer, Neiman Marcus Group. "He understands the power of relationships and his values are imbued in everything the company stands for. Along every step of the way, he has been a remarkable partner in our journey to bring the world's most coveted…
PR Newswire
21/10/2024
Novo Nordisk A/S: Oral semaglutide demonstrates a 14% reduction in risk of major…
Bagsværd, Denmark, 21 October 2024— Novo Nordisk today announced the headline results from the SOUL cardiovascular outcomes trial. The double-blinded, randomised trial compared oral semaglutide to placebo as an adjunct to standard of care for the prevention of major adverse cardiovascular events (MACE). The trial enrolled 9,650 people with type 2 diabetes and established cardiovascular disease (CVD) and/or chronic kidney disease (CKD). As part of standard of care, 49% of patients received...
Nasdaq GlobeNewswire
21/10/2024
KFSHRC Launches Mobile Stroke Unit to Accelerate Patient Treatment
A First in the Middle East and North Africa RIYADH, Saudi Arabia, Oct.21, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has launched the first-of-its-kind Mobile Stroke Ambulance Unit in the Middle East and North Africa, bringing advanced medical technology and clinical expertise directly to stroke patients. This innovation allows the medical team to use travel time to provide immediate medical care, significantly improving recovery and...
Nasdaq GlobeNewswire
21/10/2024
Mediso introduces true theranostic TheraMAX SPECT/CT
The TheraMAX is equipped with three, large surface detectors (up to 5x larger than 12-detector CZT systems) surrounding the patients completely (360°). The 15.9mm thick NaI crystals ensure improved sensitivity for high energy photons, while the high-density sensor arrangement (123 PMT per detector head) allows high spatial resolution leading to PET-like image quality in all NM applications. The TheraMAX is equipped with three, large surface detectors (up to 5x larger than 12-detector CZT...
PR Newswire
21/10/2024
NIANCE Unveils Groundbreaking White Paper on Beauty and Longevity: Addressing…
At the heart of NIANCE's product development is its proprietary FERNESSE™ biotechnology, which maximizes the bioavailability of over 130 active ingredients used in the formulations. FERNESSE™ ensures that the body fully absorbs these powerful bioactive compounds, enhancing the efficacy of the products and ensuring deep cellular rejuvenation. At the heart of NIANCE's product development is its proprietary FERNESSE™ biotechnology, which maximizes the bioavailability of over 130 active…
PR Newswire
21/10/2024
Evosep Expanding Capabilities with New Headquarters to Support Rising Needs in…
To further support the seamless integration of its technologies into pharmaceutical and regulated laboratories, Evosep is releasing Installation Qualification (IQ) and Operational Qualification (OQ) protocols. These IQ/OQ service offerings are designed to ensure that Evosep's proteomics solutions meet the stringent quality and compliance standards required in regulated pharma environments. By providing comprehensive IQ/OQ services including innovative (patent-pending) OQ methodology and fully…
PR Newswire
21/10/2024
FRESHA INVESTS IN YUV TO REVOLUTIONIZE HAIR COLORING WITH CUTTING-EDGE…
Hair coloring is a complex service that requires precision and consistency. Yuv's technology allows salons to save personalized hair color formulas directly in customer profiles, ensuring a consistent and tailored experience for every client. For salon owners, this means they can offer a high-quality, customized service every time, which not only strengthens client loyalty and drives repeat business but also contributes to environmental sustainability. Hair coloring is a complex service that...
PR Newswire
21/10/2024
SciBase continues US expansion and will attend Fall Clinical conference
The new consensus report that was published in the JDD (September 2024 issue) will also be presented at the 44th annual Fall Clinical Dermatology Conference ("Fall Clinical 2024"). The consensus report evaluated several technologies for melanoma diagnosis and supports the use of Nevisense for its ability to significantly enhance clinician's diagnostic assessment of atypical moles by non-invasively providing them with critical information at point of care. The new consensus report that…
PR Newswire
21/10/2024
Press Release: Sanofi and CD&R partner to fuel Opella's ambitions in consumer…
Sanofi and CD&R partner to fuel Opella's ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant shareholder With 11,000 talented and passionate people bringing iconic brands to life, Opella poised to ignite new bold development journeySanofi to become a focused science-driven biopharma delivering innovative medicines and vaccines to patients Sanofi 2024 business EPS...
Nasdaq GlobeNewswire
21/10/2024
ONWARD® Medical Announces Changes to Board of Directors, Including Addition of…
Ten Hoedt is a former Medtronic President and Executive Committee Member; also a former Chairman of MedTech EuropeCommercial and digital health expert Rahma Samow will also join as DirectorCurrent Board Chairman Jan Ohrstrom and Director Fred Colen to retire from the Board at year-end after 8 years of service EINDHOVEN, the Netherlands, Oct.21, 2024(GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation...
Nasdaq GlobeNewswire
21/10/2024
Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to…
The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-01 1, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseasesCureverse receives undisclosed upfront payments and is eligible for future milestone-dependent payments and royalties, while retaining rights to commercialize CV-01 in the Republic of Korea, China, Hong Kong, Macau and TaiwanThe collaboration builds on Angelini Pharma's strong...
Nasdaq GlobeNewswire
21/10/2024
KFSHRC Leads the Way in AI-Powered Diagnostics and Minimally Invasive Surgeries
RIYADH, Saudi Arabia, Oct.20, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) continues to contribute to advancing healthcare through pioneering advancements in AI-driven diagnostics and minimally invasive surgeries, advancing precision and outcomes while contributing to global innovation.At the core of these advancements is KFSHRC's Centre for Healthcare Intelligence (CHI), which has developed numerous AI applications and predictive models that...
Nasdaq GlobeNewswire
20/10/2024
Global Health Exhibition Opens its Doors Tomorrow to Record-Breaking 100,000+…
The Exhibition's sponsors include Saudi Commission for Health Specialities as the Strategic Partner, Health Holding, NUPCO, Mobily and Lean as Foundation Partners, STC as Digital Enabler and Dallah Health and Tawuniya as Diamond Sponsors. The Exhibition's sponsors include Saudi Commission for Health Specialities as the Strategic Partner, Health Holding, NUPCO, Mobily and Lean as Foundation Partners, STC as Digital Enabler and Dallah Health and Tawuniya as Diamond Sponsors. Experts will...
PR Newswire
20/10/2024
KFSHRC Pioneers Cancer Treatment with Breakthrough Therapies and Exceptional…
RIYADH, Saudi Arabia, Oct.19, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is revolutionizing cancer treatment in the region with transformative therapies like CAR-T cell therapy and CRISPR gene editing. With over 40 years of expertise, KFSHRC has emerged as a global leader in delivering breakthrough personalized cancer care.In 2023, the Oncology Centre of Excellence treated 25% of all cancer cases in Saudi Arabia, achieving an overall...
Nasdaq GlobeNewswire
19/10/2024
Curio Digital Therapeutics Applauded by Frost & Sullivan for Enhancing Women's…
Curio's MamaLift is a general wellness product that manages neurobehavioral symptoms during pregnancy and postpartum period. It empowers mothers to manage stress, anxiety, and other neurobehavioral symptoms by providing bite-sized digital doses of CBT, evidence-based self management tools, insightful trackers, and on-demand access to health coaches. Curio's "digital dose" approach uniquely ensures user-friendliness, requiring only 10 minutes of daily engagement. It caters to the busy…
PR Newswire
19/10/2024
Accord Healthcare receives positive CHMP opinion for IMULDOSA®, a ustekinumab…
Mr. Paul Tredwell, Executive Vice President of Accord Healthcare, said, "We are delighted with the positive CHMP opinion for Imuldosa®. This further strengthens our established autoimmune franchise, where Accord already has several leading speciality brands. The recommendation affirms Accord's continued strategy to expand its speciality business with an industry-leading portfolio, this positive opinion, combined with a further 10 biosimilars in development, reaffirms our commitment to…
PR Newswire
19/10/2024
Roche's Vabysmo improved vision in underrepresented populations with diabetic…
The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic macular edema (DME) treated with Vabysmo who identify as African American, Black, Hispanic and Latino 1 Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies 1 These racial and ethnic groups aredisproportionately affected by diabetes and at higher risk of developing DME, a leading cause of vision...
Nasdaq GlobeNewswire
18/10/2024
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced upcoming participation at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting, October 24 – 28 th, 2024 in Boston, Massachusetts. This year's meeting will feature a “Product Theater” onWhat Defines an Optimal Peanut Allergy Treatment?...
Nasdaq GlobeNewswire
18/10/2024
RAMSAY SANTE :Annual results at the end of June 2024
PRESS RELEASE Paris, 18 thOctober 2024 Annual results at the end of June 2024As a mission-driven company, Ramsay Santé, thanks to its employees and medical community, is committed to expanding its pioneering role in access to care and medical innovation benefiting 12.6 million patients in France, the 3 Nordics countries and Italy.Ramsay Santé has further implemented its “Yes We Care 2025” unique and differentiating strategy to offer integrated care to patients,...
Nasdaq GlobeNewswire
18/10/2024
Microfiber Cleaning Cloth Market Surges to USD 11043.79 Million by 2030…
Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=142099 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=142099 Browse in-depth TOC onMicrofiber Cleaning Cloth Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Microfiber Cleaning Cloth Market Overview Increasing Demand for Eco-friendly Cleaning Solutions The growing shift towards eco-friendly and sustainable cleaning...
PR Newswire
18/10/2024
Altri Comunicati
